• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Basel Medical Group Ltd

    1/23/26 4:30:24 PM ET
    $BMGL
    Medical/Nursing Services
    Health Care
    Get the next $BMGL alert in real time by email
    6-K 1 form6-k.htm 6-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of January 2026

     

    Commission File Number: 001-42527

     

    Basel Medical Group Ltd

     

    6 Napier Road,

    Unit #02-10/11 Gleneagles Medical Centre

    Singapore 258499

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F ☒ Form 40-F ☐

     

     

     

     

     

     

    Exhibit Index

     

    Exhibit No.   Description
    99.1   Press Release – Receipt of Delinquency Notification from Nasdaq

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Basel Medical Group Ltd
         
      By: /s/ Darren Yen Feng Chhoa
      Name:  Dr. Darren Yen Feng Chhoa
      Title: Chief Executive Officer
         
    Date: January 23, 2026    

     

     

    Get the next $BMGL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BMGL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BMGL
    SEC Filings

    View All

    SEC Form 6-K filed by Basel Medical Group Ltd

    6-K - Basel Medical Group Ltd (0002004489) (Filer)

    3/30/26 7:05:07 AM ET
    $BMGL
    Medical/Nursing Services
    Health Care

    SEC Form 6-K filed by Basel Medical Group Ltd

    6-K - Basel Medical Group Ltd (0002004489) (Filer)

    3/24/26 6:30:19 AM ET
    $BMGL
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form 20-F/A filed by Basel Medical Group Ltd

    20-F/A - Basel Medical Group Ltd (0002004489) (Filer)

    3/13/26 7:30:44 AM ET
    $BMGL
    Medical/Nursing Services
    Health Care

    $BMGL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Compliance With Nasdaq Periodic Filing Requirement

    Singapore, March 24, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company") today announced that it has received notification from Nasdaq that based on the Company's amended annual report on Form 20-F for the fiscal year of 2025, which was filed with the SEC on March 13, 2026, Nasdaq Staff has now determined that the Company has complied with the periodic filing requirement for The Nasdaq Stock Market under Listing Rule 5250(c)(1) (the "Periodic Filing Rule"). Accordingly, the prior deficiency relating to the Periodic Filing Rule has now been resolved. About Basel Medical Group Ltd Basel Medical is a Singapore-based provider of orthopedic and trauma services, spor

    3/24/26 6:30:00 AM ET
    $BMGL
    Medical/Nursing Services
    Health Care

    Receipt of Delinquency Notification from Nasdaq

    Singapore, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company"), today announced that it has received notification from Nasdaq that based on the closing bid price of the Company's shares for the last 30 consecutive business days, the Company no longer meets the requirements under Nasdaq's Listing Rules (the "Rules") for listed securities to maintain a minimum bid price of $1 per share. The Rules provide the Company a compliance period of 180 calendar days in which to regain compliance. If at any time during this 180 day period the closing bid price of the Company's security is at least $1 for a minimum of ten consecutive business days, Nasdaq will provid

    1/23/26 4:30:00 PM ET
    $BMGL
    Medical/Nursing Services
    Health Care

    Receipt of Delinquency Notification from Nasdaq

    Singapore, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (NASDAQ:BMGL) (the "Company"), today announced that it has received notification from Nasdaq that the Company's annual report on Form 20-F for the fiscal year ended June 30, 2025 was incomplete and that the Company is delinquent in its filing obligations. This was because such report failed to include an opinion from the Company's auditor, NLA DFK Assurance PAC, on the Company's financial statements. Pursuant to Listing Rule 5250(c)(1), companies shall timely file all required periodic financial reports with the United States Securities and Exchange Commission, and annual reports filed shall contain audited financial stat

    12/1/25 4:30:00 PM ET
    $BMGL
    Medical/Nursing Services
    Health Care

    $BMGL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Freudenthaler Paul D

    3 - Basel Medical Group Ltd (0002004489) (Issuer)

    3/4/26 4:20:17 PM ET
    $BMGL
    Medical/Nursing Services
    Health Care